Gliclazide 80mg/5ml oral suspension
BNF presentation 0601021M0AAASAS within chapter Endocrine System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
0601021M0AAASAS
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
307
NHS spend (£)
£5,575.97
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 41 |
| February 2025 | 1 |
| December 2024 | 11 |
| November 2024 | 37 |
| October 2024 | 51 |
| September 2024 | 1 |
| August 2024 | 3 |
| July 2024 | 54 |
| May 2024 | 12 |
| July 2021 | 16 |
| June 2021 | 7 |
| December 2020 | 28 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 20 | No data available |
| Unknown pharmacy | 7 | No data available |
|
Newbold Verdon Med.Pract.
ODS C82051
|
6 | 04V - LEICESTER, LEICS & RUTLAND ICB |
| Unknown pharmacy | 6 | No data available |
|
Whitby Group Practice
ODS B82017
|
5 | 42D - HUMBER AND NORTH YORKSHIRE ICB |
| Unknown pharmacy | 5 | No data available |
| Unknown pharmacy | 5 | No data available |
| Unknown pharmacy | 5 | No data available |
| Unknown pharmacy | 5 | No data available |
| Unknown pharmacy | 5 | No data available |